| Cvs Pharmacy # 03615 | |
| 1899 N Highland Ave, Clearwater, Florida 33755 | |
| (727) 441-4585 |
| Name | Cvs Pharmacy # 03615 |
|---|---|
| Organization Name | Holiday Cvs Llc |
| Location | 1899 N Highland Ave, Clearwater, Florida 33755 |
| Type | Pharmacy |
| Phone | (727) 441-4585 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Children born just a few weeks too early are significantly more likely to have behavioural and/or emotional problems in the pre-school years, suggests research published online in the Archives of Disease in Childhood.
Northwest Biotherapeutics, Inc., developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors. The funding included $1.75 million in purchases of restricted common stock of the Company by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.
SCHOTT introduced its adaptiQ™ system for ready-to-use pharmaceutical vials, which allows for more flexible manufacturing concepts and more efficient filling. Designed in close collaboration with filling line manufacturers to meet the pharmaceutical industry's process requirements, SCHOTT adaptiQ consists of a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
› Verified 4 days ago
| NPI Number | 1962506873 |
| Organization Name | HOLIDAY CVS LLC |
| Doing Business As | CVS PHARMACY 03615 |
| Type | Pharmacy |
| Address | 1899 N Highland Ave, Clearwater, FL 33755 |
| Phone Number | 727-441-4585 |
News Archive
Children born just a few weeks too early are significantly more likely to have behavioural and/or emotional problems in the pre-school years, suggests research published online in the Archives of Disease in Childhood.
Northwest Biotherapeutics, Inc., developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors. The funding included $1.75 million in purchases of restricted common stock of the Company by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.
SCHOTT introduced its adaptiQ™ system for ready-to-use pharmaceutical vials, which allows for more flexible manufacturing concepts and more efficient filling. Designed in close collaboration with filling line manufacturers to meet the pharmaceutical industry's process requirements, SCHOTT adaptiQ consists of a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
› Verified 4 days ago
News Archive
Children born just a few weeks too early are significantly more likely to have behavioural and/or emotional problems in the pre-school years, suggests research published online in the Archives of Disease in Childhood.
Northwest Biotherapeutics, Inc., developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors. The funding included $1.75 million in purchases of restricted common stock of the Company by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.
SCHOTT introduced its adaptiQ™ system for ready-to-use pharmaceutical vials, which allows for more flexible manufacturing concepts and more efficient filling. Designed in close collaboration with filling line manufacturers to meet the pharmaceutical industry's process requirements, SCHOTT adaptiQ consists of a patented nest that securely holds as many as 100 clean and sterile vials in an industry standard tub.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.
A decade-long JDRF-funded study led by the Institute of Diabetes Research in Helmholtz Zentrum M-nchen, Germany, is providing a deeper understanding of the link between autoantibodies and the risk of developing type 1 diabetes, highlighting the importance of pre-diabetes research into possible preventions for the disease.
› Verified 4 days ago
Lincourt Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 501 S Lincoln Ave, Clearwater, Florida 33756 Phone: (727) 447-4248 | |
Publix Pharmacy #1300 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1921 N Belcher Rd, Clearwater, Florida 33763 Phone: (727) 712-3480 | |
Publix Pharmacy # 0386 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1520 N. Mcmullen Booth Rd, Clearwater, Florida 33759 Phone: (727) 726-1061 | |
Publix Pharmacy #3219 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 300 Pinellas St, Clearwater, Florida 33756 Phone: (727) 462-3311 | |
Publix Pharmacy #1562 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 200 Island Way, Clearwater, Florida 33767 Phone: (727) 373-3675 |